Profile http://med.stanford.edu/profiles/Stanley_Schrier/ Email this page Printer friendly version

Key Documents

Stanley Schrier

Emeritus (Active) Professor, Medicine - Hematology
Emeritus Faculty, Acad Council, Medicine - Hematology
Member, Cancer Center

Contact Information

Clinical Offices

Hematology Clinic 875 Blake Wilbur Dr Clinic C Stanford, CA 94305-5820
Telephone Work (650) 498-6000 Fax (650) 498-5030
Academic Offices

Personal Information
Email sschrier@stanford.edu Tel (650) 723-8688
Not for medical emergencies or patient use

Clinical Focus

Cancer > Hematology
Cancer > Hematology > Leukemia - Acute and Chronic
Hematology
Leukemia - Hematology

Professional Education

Board Certification: Hematology, American Board of Internal Medicine (1976)
Board Certification: Internal Medicine, American Board of Internal Medicine (1961)
University of Chicago Hospitals (1959) IL
University of Michigan School of Public Health (1956) MI
Johns Hopkins University School of Medicine (1955) MD
Johns Hopkins University School of Medicine (1954) MD

Clinical Trials

Publications

Anemia in the elderly: introduction. Price EA, Schrier SL. Semin Hematol. 2008; 45 (4): 207-9
Lung cancer presenting with amegakaryocytic thrombocytopenia. Witteles WH, Schrier SL, Wakelee HA. J Clin Oncol. 2008; 26 (7): 1171-4
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Tam BY, Wei K, Rudge JS, Hoffman J, Holash J, Park SK, Yuan J, Hefner C, Chartier C, Lee JS, Jiang S, Nayak NR, Niyak NR, Kuypers FA, Ma L, Sundram U, Wu G, Garcia JA, Schrier SL, Maher JJ, Johnson RS, Yancopoulos GD, Mulligan RC, Kuo CJ. Nat Med. 2006; 12 (7): 793-800
New strategies in the treatment of the thalassemias. Schrier SL, Angelucci E. Annu Rev Med. 2005; 56 157-71
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DG, Coutré SE. Blood. 2004; 103 (8): 2879-91
The role of oxidant injury in the pathophysiology of human thalassemias. Schrier SL, Centis F, Verneris M, Ma L, Angelucci E. Redox Rep. 2003; 8 (5): 241-5
Pathophysiology of thalassemia. Schrier SL, Curr Opin Hematol. 2002; 9 (2): 123-6
The unusual pathobiology of hemoglobin constant spring red blood cells. Schrier SL, Bunyaratvej A, Khuhapinant A, Fucharoen S, Aljurf M, Snyder LM, Keifer CR, Ma L, Mohandas N. Blood. 1997; 89 (5): 1762-9
Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation. Schrier SL, West J Med. 1997; 167 (2): 82-9
Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. Yenari MA, de Crespigny A, Palmer JT, Roberts S, Schrier SL, Albers GW, Moseley ME, Steinberg GK. J Cereb Blood Flow Metab. 1997; 17 (4): 401-11
Pathobiology of thalassemic erythrocytes. Schrier SL, Curr Opin Hematol. 1997; 4 (2): 75-8
Thalassemia: pathophysiology of red cell changes. Schrier SL, Annu Rev Med. 1994; 45 211-8
Oxidative red blood cell membrane injury in the pathophysiology of severe mouse beta-thalassemia. Advani R, Rubin E, Mohandas N, Schrier SL. Blood. 1992; 79 (4): 1064-7
Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. Advani R, Sorenson S, Shinar E, Lande W, Rachmilewitz E, Schrier SL. Blood. 1992; 79 (4): 1058-63
Mechanisms of amphipath-induced stomatocytosis in human erythrocytes. Schrier SL, Zachowski A, Devaux PF. Blood. 1992; 79 (3): 782-6
Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties. Schrier SL, Mohandas N. Blood. 1992; 79 (6): 1586-92
Transmembrane redistribution of phospholipids of the human red cell membrane during hypotonic hemolysis. Schrier SL, Zachowski A, Hervé P, Kader JC, Devaux PF. Biochim Biophys Acta. 1992; 1105 (1): 170-6
Myosin content and distribution in human neonatal erythrocytes are different from adult erythrocytes. Colin FC, Schrier SL. Blood. 1991; 78 (11): 3052-5
Spontaneous endocytosis in human neonatal and adult red blood cells: comparison to drug-induced endocytosis and to receptor-mediated endocytosis. Colin FC, Schrier SL. Am J Hematol. 1991; 37 (1): 34-40
Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. Schrier SL, Rachmilewitz E, Mohandas N. Blood. 1989; 74 (6): 2194-202
Comparison of transferrin receptor-mediated endocytosis and drug-induced endocytosis in human neonatal and adult RBCs. Thatte HS, Schrier SL. Blood. 1988; 72 (5): 1693-700
Shape changes and deformability in human erythrocyte membranes. Schrier SL, J Lab Clin Med. 1987; 110 (6): 791-7